Heart transplantation remains the optimal long-term treatment for appropriate patients with advanced heart failure. However, the donor heart shortage is a limiting factor, and the risk profile of transplant candidates is worsening. In this landscape, the utility of conventional cold static storage for donor hearts is increasingly limited. In this Clinical Outlook, we discuss new methods of donor heart preservation that are transforming the future of heart transplantation.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kirschner, M. et al. Comparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failure. J. Thorac. Cardiovasc. Surg. 169, 148–159 (2025).
Sicim, H., Tam, W. S. V. & Tang, P. C. Primary graft dysfunction in heart transplantation: the challenge to survival. J. Cardiothorac. Surg. 19, 313 (2024).
Russo, M. J. et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J. Thorac. Cardiovasc. Surg. 133, 554–559 (2007).
Hendry, P. J., Walley, V. M., Koshal, A., Masters, R. G. & Keon, W. J. Are temperatures attained by donor hearts during transport too cold? J. Thorac. Cardiovasc. Surg. 98, 517–522 (1989).
Paez, J. R. et al. Investigating cardiac temperature during heart transplantation using the static cold storage paradigm. Transplantation 109, e148–e156 (2025).
Moayedifar, R. et al. Recipient outcomes with extended criteria donors using advanced heart preservation: an analysis of the GUARDIAN-Heart registry. J. Heart Lung Transplant. 43, 673–680 (2024).
McGiffin, D. C. et al. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: results of the Australian and New Zealand trial. J. Heart Lung Transplant. 43, 485–495 (2024).
Lebreton, G. & Leprince, P. Successful heart transplant after 12 h preservation aboard a commercial flight. Lancet 403, 1019 (2024).
Rega, F. et al. Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial. Lancet 404, 670–682 (2024).
Brouckaert, J. et al. Successful clinical transplantation of hearts donated after circulatory death using direct procurement followed by hypothermic oxygenated perfusion: a report of the first 3 cases. J. Heart Lung Transplant. 43, 1907–1910 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kaye, D.M., McGiffin, D.C. Preserving the future of heart transplantation. Nat Rev Cardiol 22, 391–392 (2025). https://doi.org/10.1038/s41569-025-01146-x
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41569-025-01146-x